Lou Silverman - 01 Jul 2026 Form 4 Insider Report for Insight Molecular Diagnostics Inc. (IMDX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Jul 2026, 20:40:23 UTC
Prior SEC filing
22 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Louis E. Silverman

Key filing fact

Lou Silverman filed Form 4 for Insight Molecular Diagnostics Inc. (IMDX) on 06 Jul 2026.

Key facts

  • This page summarizes Lou Silverman's Form 4 filing for Insight Molecular Diagnostics Inc. (IMDX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Jul 2026, 20:40.

Change

  • Previous filing in this sequence was filed on 22 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001249935 Primary reporting owner

SILVERMAN LOU

Relationship
Director
Address
C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE
Signature
/s/ Louis E. Silverman
Signature date
06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMDX transaction

Common Stock, no par value

Tax liability

Transaction value
Shares
-7,700
Change %
-12%
Price
$5.69*
Shares after
55,807
Date
01 Jul 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .